« Back to Record
Citation APA

Eggermont, A., Suciu, S., Testori, A., Santinami, M., Kruit, W. H., Marsden, J., Punt, C., Sales, F., Dummer, R., Robert, C., Schadendorf, D., Patel, P., de Schaetzen, G., Spatz, A., & Keilholz, U. (2012). Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma. Journal of clinical oncology, 30(31), 3810-3818. doi:10.1200/JCO.2011.41.3799


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/144686

Eggermont, A., Suciu, S., Testori, A., Santinami, M., Kruit, W. H., Marsden, J., Punt, C., Sales, F., Dummer, R., Robert, C., Schadendorf, D., Patel, P., de Schaetzen, G., Spatz, A., & Keilholz, U. (2012). Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma. Journal of clinical oncology, 30(31), 3810-3818. doi:10.1200/JCO.2011.41.3799